The 20 Best Melanoma of the Eye Doctors Near Me

Carol Shields is an Oncologist and an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is board certified in Ophthalmology. Dr. Shields is currently accepting new patients.

Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.

Marlana Orloff is an Oncologist practicing medicine in Philadelphia, Pennsylvania. She has been practicing medicine for over 17 years. Dr. Orloff is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Liver Embolization. Dr. Orloff is board certified in Medical Oncology and Internal Medicine. Dr. Orloff is currently accepting new patients.

Hans Grossniklaus is an Ophthalmologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 46 years. Dr. Grossniklaus is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Uveal Melanoma, Metastatic Uveal Melanoma, Vitrectomy, and Corneal Transplant. Dr. Grossniklaus is board certified in American Board Of Pathology, 1987.

I specialize in the diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. I have been working in this field for more than 20 years. Cancer of the eye is a rare disease, but once the tumor is found we begin the treatment process; the key is to be diagnosed and treated timely and correctly. My goal is to improve the prognosis of these rare eye diseases in terms of life, conservation of the eye and sight. There is a large team dedicated to ocular oncology at Duke Health. I work very closely with colleagues across Duke Eye Center and from Duke Cancer Center, specialists in children and adults, to develop the best diagnosis and treatment plans for patients suffering from cancer of the eye with the mission of providing optimal prognosis for life, eye and vision preservation. Dr. Materin is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Choroid Plexus Carcinoma, and Vitrectomy.

Jesse Berry is an Ophthalmologist practicing medicine in Los Angeles, California. Dr. Berry is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Cataract Removal. Dr. Berry is board certified in Ophthalmology. Dr. Berry is currently accepting new patients.

Takami Sato is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Sato is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Awake Craniotomy, and Liver Embolization. Dr. Sato is currently accepting new patients.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy. Dr. Handa is board certified in American Board Of Ophthalmology.

I am a medical oncologist who specializes in the treatment of patients with skin cancer. I am part of a team of surgical oncologists, dermatologists, and radiation oncologists who all work together to determine the best treatment approach for each patient. My focus is on treating patients with advanced melanoma, as well as melanoma that is at high risk for recurrence after surgery. We also treat patients with merkel cell carcinoma and advanced basal cell and cutaneous squamous cell carcinoma. We also have a number of clinical trial options available, allowing our patients access to the newest therapies available. Dr. Salama is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Primitive Neuroectodermal Tumor (PNET).

David Reichstein is an Ophthalmologist practicing medicine in Hendersonville, Tennessee. Dr. Reichstein is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Choroid Plexus Carcinoma, Uveal Melanoma, and Vitrectomy.

Evangelos Gragoudas is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Gragoudas is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Choroid Plexus Carcinoma, and Vitrectomy.

Ivana Kim is an Ophthalmologist practicing medicine in Boston, Massachusetts. Dr. Kim is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Tara Mccannel is an Ophthalmologist practicing medicine in Los Angeles, California. Dr. Mccannel is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Melanoma of the Eye, Uveal Melanoma, Metastatic Uveal Melanoma, Vitrectomy, and Cataract Removal.

Bertil Damato is an Ophthalmologist practicing medicine in San Francisco, California. Dr. Damato is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Uveal Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Iridectomy.

James Harbour is an Ophthalmologist practicing medicine in Dallas, Texas. Dr. Harbour is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Choroid Plexus Carcinoma, and Vitrectomy.

Alexander Shoushtari is an Oncologist practicing medicine in New York, New York. He has been practicing medicine for over 17 years. Dr. Shoushtari is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Melanoma, Melanoma of the Eye, Liver Embolization, and Gastrostomy. Dr. Shoushtari is currently accepting new patients.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Martine Jager practices practicing medicine in Leiden, Netherlands. Ms. Jager is rated as an Elite expert by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Uveal Melanoma, Melanoma of the Eye, Melanoma, Metastatic Uveal Melanoma, and Corneal Transplant.

Jasmine Francis is an Oncologist practicing medicine in New York, New York. Dr. Francis is rated as an Elite provider by MediFind in the treatment of Melanoma of the Eye. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.